Syndan Pharma S.R.L.
UkraineAll drugs from this manufacturer
-
The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in patients over 65 years of age under certain conditions).
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 25 mg or 100 mg ATC: L01AA09
-
The drug is used to treat a wide range of neoplasms, including breast, lung, stomach, liver, pancreatic, and rectal cancer, as well as ovarian cancer, and for the treatment of leukemia, malignant lymphomas, and soft tissue sarcomas. It is also used for the treatment of superficial bladder cancer.
Dosage form: solution for injection
Active substance Dosage epirubicin 2 mg/ml ATC: L01DB03
-
The drug is prescribed to women in postmenopause for adjuvant therapy of early-stage breast cancer (after 2–3 years of tamoxifen therapy), as well as for the treatment of advanced breast cancer if the disease progresses after the use of antiestrogens.
Dosage form: tablets, film-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
-
The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in patients with adequate bone marrow reserve.
Dosage form: powder for solution for injection or infusion
Active substance Dosage fludarabine 50 mg ATC: L01BB05
-
The drug is prescribed for the treatment of adults and children with chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), or chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Dosage form: capsules
Active substance Dosage imatinib 400 mg ATC: L01EA01
-
The drug is used to treat adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Dosage form: capsules
Active substance Dosage imatinib 100 mg ATC: L01EA01
-
The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or first-line therapy). It may also be used as neoadjuvant therapy in cases where chemotherapy is not suitable for the patient.
Dosage form: tablets, film-coated
Active substance Dosage letrozole 2.5 mg ATC: L02BG04